Fig. 6

First documented treatment after mBC diagnosis: CDK4/6 inhibitors. Among patients with or without CV comorbidities who received a CDK4/6 inhibitor as the first documented treatment for mBC (n = 1721), the proportions of those who received palbociclib, ribociclib, or abemaciclib are presented. CDK4/6, cyclin-dependent kinase 4/6; CV, cardiovascular; mBC, metastatic breast cancer